APIChangelogInfo
Memorial Day Sale Sale until May 28! Get 15% off! API Price increases May 28th so lock in at a lower rate!
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
LEXICON PHARMACEUTICALS
tastytradeTrade LXRX
LXRX Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-2024681005M10M15M20M25M30M






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-13
2025-05-13
BARKER SAM
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
AMOUYAL PHILIPPE
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
BARKER SAM
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
DEBBANE RAYMOND
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SULLIVAN DIANE
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SULLIVAN DIANE
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SWAIN JUDITH
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
AMOUYAL PHILIPPE
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
BARKER SAM
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
BARKER SAM
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
DEBBANE RAYMOND
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SULLIVAN DIANE
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SULLIVAN DIANE
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-36,810
$0.00
1
$239.66M
2025-05-13
2025-05-13
SWAIN JUDITH
M - Exercise
Common Stock
36,810
$0.00
1
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-17,862
$1.00
-17,862
1
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-45,622
$1.00
-45,622
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
F - Tax
Common Stock
-9,096
$1.00
-9,096
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
F - Tax
Common Stock
-65,308
$1.00
-65,308
1
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-17,862
$1.00
-17,862
1
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-45,622
$1.00
-45,622
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
F - Tax
Common Stock
-9,096
$1.00
-9,096
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
F - Tax
Common Stock
-65,308
$1.00
-65,308
1
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-43,434
$1.00
-43,434
1
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
F - Tax
Common Stock
-30,004
$1.00
-30,004
1
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-46,430
3
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
46,430
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-129K
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
129K
3
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Restricted Stock Units
-24,673
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Common Stock
24,673
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-138K
3
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Common Stock
138K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-43,434
$1.00
-43,434
1
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-127K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
127K
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Restricted Stock Units
-98,956
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Common Stock
98,956
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
F - Tax
Common Stock
-30,004
$1.00
-30,004
1
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-46,430
3
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
46,430
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-129K
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
129K
3
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Restricted Stock Units
-24,673
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Common Stock
24,673
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-138K
3
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Common Stock
138K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-127K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
127K
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Restricted Stock Units
-98,956
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Common Stock
98,956
3
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-17,862
$1.00
-17,862
1
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-45,622
$1.00
-45,622
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
F - Tax
Common Stock
-9,096
$1.00
-9,096
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
F - Tax
Common Stock
-65,308
$1.00
-65,308
1
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-43,434
$1.00
-43,434
1
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
F - Tax
Common Stock
-30,004
$1.00
-30,004
1
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-46,430
3
$239.66M
2025-02-28
2025-03-03
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
46,430
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-129K
3
$239.66M
2025-02-28
2025-03-03
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
129K
3
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Restricted Stock Units
-24,673
1
$239.66M
2025-02-28
2025-03-03
DEFRANCESCO LISA
SVP, IR and Corp Comm
M - Exercise
Common Stock
24,673
1
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-138K
3
$239.66M
2025-02-28
2025-03-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Common Stock
138K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-127K
3
$239.66M
2025-02-28
2025-03-03
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
127K
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Restricted Stock Units
-98,956
3
$239.66M
2025-02-28
2025-03-03
MCDERMOTT WENDY
SVP, Human Resources
M - Exercise
Common Stock
98,956
3
$239.66M
2025-02-13
2025-02-18
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Restricted Stock Units
186K
$0.00
1
$239.66M
2025-02-13
2025-02-18
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Stock Option (Right to Buy)
186K
$0.00
1
$239.66M
2025-02-13
2025-02-18
COIANTE SCOTT
SVP, Chief Financial Officer
A - Grant
Restricted Stock Units
481K
$0.00
1
$239.66M
2025-02-13
2025-02-18
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Restricted Stock Units
186K
$0.00
1
$239.66M
2025-02-13
2025-02-18
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Stock Option (Right to Buy)
186K
$0.00
1
$239.66M
2025-02-13
2025-02-18
COIANTE SCOTT
SVP, Chief Financial Officer
A - Grant
Restricted Stock Units
481K
$0.00
1
$239.66M
2025-02-13
2025-02-18
COIANTE SCOTT
SVP, Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
721K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CORRIGAN BRIAN
SVP, Regulatory & QA
A - Grant
Restricted Stock Units
449K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CORRIGAN BRIAN
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
673K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Restricted Stock Units
510K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
766K
$0.00
1
$239.66M
2025-02-13
2025-02-18
DEFRANCESCO LISA
VP, IR and Corp Comm
A - Grant
Restricted Stock Units
385K
$0.00
1
$239.66M
2025-02-13
2025-02-18
DEFRANCESCO LISA
VP, IR and Corp Comm
A - Grant
Stock Option (Right to Buy)
577K
$0.00
1
$239.66M
2025-02-13
2025-02-18
EXTON MICHAEL
Chief Executive Officer
A - Grant
Restricted Stock Units
1.51M
$0.00
1
$239.66M
2025-02-13
2025-02-18
EXTON MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
2.26M
$0.00
1
$239.66M
2025-02-13
2025-02-18
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Restricted Stock Units
607K
$0.00
1
$239.66M
2025-02-13
2025-02-18
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
910K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
502K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
753K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MCDERMOTT WENDY
SVP, Human Resources
A - Grant
Restricted Stock Units
433K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MCDERMOTT WENDY
SVP, Human Resources
A - Grant
Stock Option (Right to Buy)
650K
$0.00
1
$239.66M
2025-02-13
2025-02-18
COIANTE SCOTT
SVP, Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
721K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CORRIGAN BRIAN
SVP, Regulatory & QA
A - Grant
Restricted Stock Units
449K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CORRIGAN BRIAN
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
673K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Restricted Stock Units
510K
$0.00
1
$239.66M
2025-02-13
2025-02-18
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
766K
$0.00
1
$239.66M
2025-02-13
2025-02-18
DEFRANCESCO LISA
VP, IR and Corp Comm
A - Grant
Restricted Stock Units
385K
$0.00
1
$239.66M
2025-02-13
2025-02-18
DEFRANCESCO LISA
VP, IR and Corp Comm
A - Grant
Stock Option (Right to Buy)
577K
$0.00
1
$239.66M
2025-02-13
2025-02-18
EXTON MICHAEL
Chief Executive Officer
A - Grant
Restricted Stock Units
1.51M
$0.00
1
$239.66M
2025-02-13
2025-02-18
EXTON MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
2.26M
$0.00
1
$239.66M
2025-02-13
2025-02-18
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Restricted Stock Units
607K
$0.00
1
$239.66M
2025-02-13
2025-02-18
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
910K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
502K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
753K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MCDERMOTT WENDY
SVP, Human Resources
A - Grant
Restricted Stock Units
433K
$0.00
1
$239.66M
2025-02-13
2025-02-18
MCDERMOTT WENDY
SVP, Human Resources
A - Grant
Stock Option (Right to Buy)
650K
$0.00
1
$239.66M
2025-01-02
2025-01-02
COIANTE SCOTT
SVP, Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
230K
$0.00
1
$239.66M
2024-12-02
2024-12-02
CHEUNG IVAN
A - Grant
Stock Option (Right to Buy)
187K
$0.00
1
$239.66M
2024-08-15
2024-08-15
COATS LONNEL
Chief Executive Officer
S - Sale
-300K
$2.00
-600K
1
$239.66M
2024-08-12
2024-08-12
CORRIGAN BRIAN
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$239.66M
2024-07-08
2024-07-08
EXTON MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
1.68M
$0.00
1
$239.66M
2024-07-08
2024-07-08
WADE JEFFREY
President and COO
A - Grant
Stock Option (Right to Buy)
307K
$0.00
1
$239.66M
2024-05-10
2024-05-14
ARTAL INTERNATIONAL S.C.A.
M - Exercise
Series A Convertible Preferred Stock
-1.15M
$0.00
1
$239.66M
2024-05-10
2024-05-14
ARTAL INTERNATIONAL S.C.A.
A - Grant
Series A Convertible Preferred Stock
1.15M
$109.00
125M
1
$239.66M
2024-05-10
2024-05-14
ARTAL INTERNATIONAL S.C.A.
M - Exercise
Common Stock
58M
1
$239.66M
2024-05-13
2024-05-13
AMOUYAL PHILIPPE
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
BARKER SAM
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
BARKER SAM
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
DEBBANE RAYMOND
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
DEBBANE RAYMOND
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
LEFKOWITZ ROBERT MD
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
LEFKOWITZ ROBERT MD
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
SOBECKI CHRISTOPHER
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
AMOUYAL PHILIPPE
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
SOBECKI CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
SULLIVAN DIANE
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
SULLIVAN DIANE
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-05-13
2024-05-13
SWAIN JUDITH
A - Grant
Restricted Stock Units
36,810
$0.00
1
$239.66M
2024-05-13
2024-05-13
SWAIN JUDITH
A - Grant
Stock Option (Right to Buy)
44,906
$0.00
1
$239.66M
2024-04-28
2024-04-29
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
AMOUYAL PHILIPPE
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
BARKER SAM
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
BARKER SAM
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
DEBBANE RAYMOND
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
LEFKOWITZ ROBERT MD
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
LEFKOWITZ ROBERT MD
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-8,032
$0.00
1
$239.66M
2024-04-28
2024-04-29
SWAIN JUDITH
M - Exercise
Common Stock
8,032
$0.00
1
$239.66M
2024-03-13
2024-03-13
ARTAL INTERNATIONAL S.C.A.
A - Grant
Series A Convertible Preferred Stock
1.15M
$109.00
125M
1
$239.66M
2024-02-28
2024-02-29
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-11,793
$3.00
-35,379
1
$239.66M
2024-02-28
2024-02-29
COATS LONNEL
Chief Executive Officer
F - Tax
Common Stock
-61,371
$3.00
-184K
1
$239.66M
2024-02-28
2024-02-29
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-25,604
$3.00
-76,812
1
$239.66M
2024-02-28
2024-02-29
GRANOWITZ CRAIG
SVP, Chief Medical Officer
F - Tax
Common Stock
-31,265
$3.00
-93,795
1
$239.66M
2024-02-28
2024-02-29
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
F - Tax
Common Stock
-24,353
$3.00
-73,059
1
$239.66M
2024-02-28
2024-02-29
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-24,408
$3.00
-73,224
1
$239.66M
2024-02-28
2024-02-29
MCDERMOTT WENDY
VP, Human Resources
F - Tax
Common Stock
-22,425
$3.00
-67,275
1
$239.66M
2024-02-28
2024-02-29
WADE JEFFREY
President and CFO
F - Tax
Common Stock
-37,691
$3.00
-113K
1
$239.66M
2024-02-28
2024-02-29
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-29,243
3
$239.66M
2024-02-28
2024-02-29
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
29,243
3
$239.66M
2024-02-28
2024-02-29
COATS LONNEL
Chief Executive Officer
M - Exercise
Restricted Stock Units
-245K
3
$239.66M
2024-02-28
2024-02-29
COATS LONNEL
Chief Executive Officer
M - Exercise
Common Stock
245K
3
$239.66M
2024-02-28
2024-02-29
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-68,303
3
$239.66M
2024-02-28
2024-02-29
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
68,303
3
$239.66M
2024-02-28
2024-02-29
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-63,706
2
$239.66M
2024-02-28
2024-02-29
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Common Stock
63,706
2
$239.66M
2024-02-28
2024-02-29
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Restricted Stock Units
-67,400
3
$239.66M
2024-02-28
2024-02-29
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Common Stock
67,400
3
$239.66M
2024-02-28
2024-02-29
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-67,546
3
$239.66M
2024-02-28
2024-02-29
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
67,546
3
$239.66M
2024-02-28
2024-02-29
MCDERMOTT WENDY
VP, Human Resources
M - Exercise
Restricted Stock Units
-46,641
2
$239.66M
2024-02-28
2024-02-29
MCDERMOTT WENDY
VP, Human Resources
M - Exercise
Common Stock
46,641
2
$239.66M
2024-02-28
2024-02-29
WADE JEFFREY
President and CFO
M - Exercise
Restricted Stock Units
-97,564
3
$239.66M
2024-02-28
2024-02-29
WADE JEFFREY
President and CFO
M - Exercise
Common Stock
97,564
3
$239.66M
2024-02-08
2024-02-12
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Restricted Stock Units
223K
$0.00
1
$239.66M
2024-02-08
2024-02-12
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Restricted Stock Units
59,660
$0.00
1
$239.66M
2024-02-08
2024-02-12
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Stock Option (Right to Buy)
59,660
$0.00
1
$239.66M
2024-02-08
2024-02-12
COATS LONNEL
Chief Executive Officer
A - Grant
Restricted Stock Units
770K
$0.00
1
$239.66M
2024-02-08
2024-02-12
COATS LONNEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
770K
$0.00
1
$239.66M
2024-02-08
2024-02-12
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Restricted Stock Units
208K
$0.00
1
$239.66M
2024-02-08
2024-02-12
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
208K
$0.00
1
$239.66M
2024-02-08
2024-02-12
GARNER THOMAS
SVP, Chief Commercial Officer
A - Grant
Restricted Stock Units
227K
$0.00
1
$239.66M
2024-02-08
2024-02-12
GARNER THOMAS
SVP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
227K
$0.00
1
$239.66M
2024-02-08
2024-02-12
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
223K
$0.00
1
$239.66M
2024-02-08
2024-02-12
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Restricted Stock Units
204K
$0.00
1
$239.66M
2024-02-08
2024-02-12
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
204K
$0.00
1
$239.66M
2024-02-08
2024-02-12
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
205K
$0.00
1
$239.66M
2024-02-08
2024-02-12
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
205K
$0.00
1
$239.66M
2024-02-08
2024-02-12
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Restricted Stock Units
157K
$0.00
1
$239.66M
2024-02-08
2024-02-12
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Stock Option (Right to Buy)
157K
$0.00
1
$239.66M
2024-02-08
2024-02-12
WADE JEFFREY
President and CFO
A - Grant
Restricted Stock Units
314K
$0.00
1
$239.66M
2024-02-08
2024-02-12
WADE JEFFREY
President and CFO
A - Grant
Stock Option (Right to Buy)
314K
$0.00
1
$239.66M
2023-11-16
2023-11-17
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
90,000
$1.00
90,000
1
$239.66M
2023-11-13
2023-11-14
AMOUYAL PHILIPPE
P - Purchase
Common Stock
200K
$1.00
200K
1
$239.66M
2023-11-10
2023-11-13
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$239.66M
2023-10-12
2023-10-12
DEBBANE RAYMOND
P - Purchase
Common Stock
149K
$1.00
149K
1
$239.66M
2023-10-11
2023-10-12
DEBBANE RAYMOND
P - Purchase
Common Stock
343K
$1.00
343K
1
$239.66M
2023-10-10
2023-10-12
DEBBANE RAYMOND
P - Purchase
Common Stock
508K
$1.00
508K
1
$239.66M
2023-10-09
2023-10-11
GARNER THOMAS
SVP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
249K
$0.00
1
$239.66M
2023-09-14
2023-09-14
WADE JEFFREY
President and CFO
P - Purchase
Common Stock
10,000
$1.00
10,000
1
$239.66M
2023-08-04
2023-08-07
MCDERMOTT WENDY
VP, Human Resources
P - Purchase
Common Stock
6,000
$2.00
12,000
1
$239.66M
2023-07-27
2023-07-31
SULLIVAN DIANE
A - Grant
Stock Option (Right to Buy)
96,515
$0.00
1
$239.66M
2023-07-12
2023-07-12
SETH KIERNAN
VP, Chief Commercial Officer
S - Sale
-19,000
$2.00
-38,000
1
$239.66M
2023-06-29
2023-06-29
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$239.66M
2023-06-23
2023-06-27
MCDERMOTT WENDY
VP, Human Resources
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$239.66M
2023-06-26
2023-06-26
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$239.66M
2023-06-23
2023-06-26
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
10,000
$2.00
20,000
1
$239.66M
2023-06-22
2023-06-22
COATS LONNEL
Chief Executive Officer
P - Purchase
Common Stock
40,000
$2.00
80,000
1
$239.66M
2023-06-20
2023-06-20
WADE JEFFREY
President and CFO
P - Purchase
Common Stock
12,000
$2.00
24,000
2
$239.66M
2023-06-05
2023-06-05
ARTAL INTERNATIONAL S.C.A.
P - Purchase
Common Stock
28M
$3.00
83M
1
$239.66M
2023-05-21
2023-05-22
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
AMOUYAL PHILIPPE
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
BARKER SAM
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
BARKER SAM
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
DEBBANE RAYMOND
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
LEFKOWITZ ROBERT MD
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
LEFKOWITZ ROBERT MD
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
NIES ALAN
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
NIES ALAN
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
PALANTONI FRANK
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
PALANTONI FRANK
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-9,302
$0.00
1
$239.66M
2023-05-21
2023-05-22
SWAIN JUDITH
M - Exercise
Common Stock
9,302
$0.00
1
$239.66M
2023-04-28
2023-04-28
AMOUYAL PHILIPPE
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
AMOUYAL PHILIPPE
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
BARKER SAM
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
BARKER SAM
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
DEBBANE RAYMOND
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
DEBBANE RAYMOND
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
LEFKOWITZ ROBERT MD
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
LEFKOWITZ ROBERT MD
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
NIES ALAN
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
NIES ALAN
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
PALANTONI FRANK
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
PALANTONI FRANK
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
SOBECKI CHRISTOPHER
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
SOBECKI CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-04-28
2023-04-28
SWAIN JUDITH
A - Grant
Restricted Stock Units
8,032
$0.00
1
$239.66M
2023-04-28
2023-04-28
SWAIN JUDITH
A - Grant
Stock Option (Right to Buy)
12,658
$0.00
1
$239.66M
2023-02-28
2023-03-01
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Common Stock
52,886
3
$239.66M
2023-02-28
2023-03-01
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-5,330
$2.00
-10,660
1
$239.66M
2023-02-28
2023-03-01
COATS LONNEL
Chief Executive Officer
F - Tax
Common Stock
-50,971
$2.00
-102K
1
$239.66M
2023-02-28
2023-03-01
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-20,537
$2.00
-41,074
1
$239.66M
2023-02-28
2023-03-01
GRANOWITZ CRAIG
SVP, Chief Medical Officer
F - Tax
Common Stock
-12,732
$2.00
-25,464
1
$239.66M
2023-02-28
2023-03-01
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
F - Tax
Common Stock
-19,118
$2.00
-38,236
1
$239.66M
2023-02-28
2023-03-01
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-20,946
$2.00
-41,892
1
$239.66M
2023-02-28
2023-03-01
MCDERMOTT WENDY
VP, Human Resources
F - Tax
Common Stock
-6,465
$2.00
-12,930
1
$239.66M
2023-02-28
2023-03-01
SETH KIERNAN
VP, Chief Commercial Officer
F - Tax
Common Stock
-11,813
$2.00
-23,626
1
$239.66M
2023-02-28
2023-03-01
WADE JEFFREY
President and CFO
F - Tax
Common Stock
-30,255
$2.00
-60,510
1
$239.66M
2023-02-28
2023-03-01
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-18,717
3
$239.66M
2023-02-28
2023-03-01
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
18,717
3
$239.66M
2023-02-28
2023-03-01
COATS LONNEL
Chief Executive Officer
M - Exercise
Restricted Stock Units
-209K
3
$239.66M
2023-02-28
2023-03-01
COATS LONNEL
Chief Executive Officer
M - Exercise
Common Stock
209K
3
$239.66M
2023-02-28
2023-03-01
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-55,877
3
$239.66M
2023-02-28
2023-03-01
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
55,877
3
$239.66M
2023-02-28
2023-03-01
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Restricted Stock Units
-27,917
1
$239.66M
2023-02-28
2023-03-01
GRANOWITZ CRAIG
SVP, Chief Medical Officer
M - Exercise
Common Stock
27,917
1
$239.66M
2023-02-28
2023-03-01
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Restricted Stock Units
-52,886
3
$239.66M
2023-02-28
2023-03-01
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-57,943
3
$239.66M
2023-02-28
2023-03-01
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
57,943
3
$239.66M
2023-02-28
2023-03-01
MCDERMOTT WENDY
VP, Human Resources
M - Exercise
Restricted Stock Units
-18,943
1
$239.66M
2023-02-28
2023-03-01
MCDERMOTT WENDY
VP, Human Resources
M - Exercise
Common Stock
18,943
1
$239.66M
2023-02-28
2023-03-01
SETH KIERNAN
VP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-43,082
3
$239.66M
2023-02-28
2023-03-01
SETH KIERNAN
VP, Chief Commercial Officer
M - Exercise
Common Stock
43,082
3
$239.66M
2023-02-28
2023-03-01
WADE JEFFREY
President and CFO
M - Exercise
Restricted Stock Units
-78,916
3
$239.66M
2023-02-28
2023-03-01
WADE JEFFREY
President and CFO
M - Exercise
Common Stock
78,916
3
$239.66M
2023-02-09
2023-02-13
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Stock Option (Right to Buy)
71,670
$0.00
1
$239.66M
2023-02-09
2023-02-13
COATS LONNEL
Chief Executive Officer
A - Grant
Restricted Stock Units
361K
$0.00
1
$239.66M
2023-02-09
2023-02-13
COATS LONNEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
1.08M
$0.00
1
$239.66M
2023-02-09
2023-02-13
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Restricted Stock Units
100K
$0.00
1
$239.66M
2023-02-09
2023-02-13
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
301K
$0.00
1
$239.66M
2023-02-09
2023-02-13
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Restricted Stock Units
107K
$0.00
1
$239.66M
2023-02-09
2023-02-13
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
322K
$0.00
1
$239.66M
2023-02-09
2023-02-13
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Restricted Stock Units
98,270
$0.00
1
$239.66M
2023-02-09
2023-02-13
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
295K
$0.00
1
$239.66M
2023-02-09
2023-02-13
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
98,710
$0.00
1
$239.66M
2023-02-09
2023-02-13
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
296K
$0.00
1
$239.66M
2023-02-09
2023-02-13
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Restricted Stock Units
47,780
$0.00
1
$239.66M
2023-02-09
2023-02-13
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Restricted Stock Units
83,090
$0.00
1
$239.66M
2023-02-09
2023-02-13
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Stock Option (Right to Buy)
249K
$0.00
1
$239.66M
2023-02-09
2023-02-13
SETH KIERNAN
VP, Chief Commercial Officer
A - Grant
Restricted Stock Units
93,370
$0.00
1
$239.66M
2023-02-09
2023-02-13
SETH KIERNAN
VP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
280K
$0.00
1
$239.66M
2023-02-09
2023-02-13
WADE JEFFREY
President and CFO
A - Grant
Restricted Stock Units
147K
$0.00
1
$239.66M
2023-02-09
2023-02-13
WADE JEFFREY
President and CFO
A - Grant
Stock Option (Right to Buy)
442K
$0.00
1
$239.66M
2022-08-05
2022-08-09
ARTAL INTERNATIONAL S.C.A.
P - Purchase
Common Stock
2.43M
$3.00
7.28M
1
$239.66M
2022-08-05
2022-08-09
INVUS US PARTNERS LLC
P - Purchase
Common Stock
147K
$3.00
442K
1
$239.66M
2022-08-01
2022-08-01
ARTAL INTERNATIONAL S.C.A.
P - Purchase
Common Stock
16M
$3.00
49M
1
$239.66M
2022-08-01
2022-08-01
DEBBANE RAYMOND
P - Purchase
Common Stock
983K
$3.00
2.95M
1
$239.66M
2022-08-01
2022-08-01
INVUS US PARTNERS LLC
P - Purchase
Common Stock
983K
$3.00
2.95M
1
$239.66M
2022-05-21
2022-05-23
AMOUYAL PHILIPPE
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
AMOUYAL PHILIPPE
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
BARKER SAM
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
BARKER SAM
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
DEBBANE RAYMOND
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
DEBBANE RAYMOND
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
LEFKOWITZ ROBERT MD
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
LEFKOWITZ ROBERT MD
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
NIES ALAN
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
NIES ALAN
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
PALANTONI FRANK
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
PALANTONI FRANK
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
SOBECKI CHRISTOPHER
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
SOBECKI CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-05-21
2022-05-23
SWAIN JUDITH
A - Grant
Restricted Stock Units
9,302
$0.00
1
$239.66M
2022-05-21
2022-05-23
SWAIN JUDITH
A - Grant
Stock Option (Right to Buy)
14,402
$0.00
1
$239.66M
2022-04-30
2022-05-02
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
AMOUYAL PHILIPPE
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
BARKER SAM
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
BARKER SAM
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
DEBBANE RAYMOND
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
LEFKOWITZ ROBERT MD
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
LEFKOWITZ ROBERT MD
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
NIES ALAN
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
NIES ALAN
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
PALANTONI FRANK
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
PALANTONI FRANK
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-4,024
$0.00
1
$239.66M
2022-04-30
2022-05-02
SWAIN JUDITH
M - Exercise
Common Stock
4,024
$0.00
1
$239.66M
2022-02-28
2022-02-28
ALEXANDER KRISTEN
VP, Finance and Accounting
F - Tax
Common Stock
-3,337
$3.00
-10,011
1
$239.66M
2022-02-28
2022-02-28
COATS LONNEL
Chief Executive Officer
F - Tax
Common Stock
-48,053
$3.00
-144K
1
$239.66M
2022-02-28
2022-02-28
CRUM BRIAN
SVP, General Counsel & Secr.
F - Tax
Common Stock
-15,059
$3.00
-45,177
1
$239.66M
2022-02-28
2022-02-28
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
F - Tax
Common Stock
-13,241
$3.00
-39,723
1
$239.66M
2022-02-28
2022-02-28
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-19,756
$3.00
-59,268
1
$239.66M
2022-02-28
2022-02-28
SETH KIERNAN
VP, Chief Commercial Officer
F - Tax
Common Stock
-8,261
$3.00
-24,783
1
$239.66M
2022-02-28
2022-02-28
WADE JEFFREY
President and CFO
F - Tax
Common Stock
-25,773
$3.00
-77,319
1
$239.66M
2022-02-28
2022-02-28
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Restricted Stock Units
-11,300
3
$239.66M
2022-02-28
2022-02-28
ALEXANDER KRISTEN
VP, Finance and Accounting
M - Exercise
Common Stock
11,300
3
$239.66M
2022-02-28
2022-02-28
COATS LONNEL
Chief Executive Officer
M - Exercise
Restricted Stock Units
-197K
3
$239.66M
2022-02-28
2022-02-28
COATS LONNEL
Chief Executive Officer
M - Exercise
Common Stock
197K
3
$239.66M
2022-02-28
2022-02-28
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-40,880
3
$239.66M
2022-02-28
2022-02-28
CRUM BRIAN
SVP, General Counsel & Secr.
M - Exercise
Common Stock
40,880
3
$239.66M
2022-02-28
2022-02-28
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Restricted Stock Units
-36,628
3
$239.66M
2022-02-28
2022-02-28
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
M - Exercise
Common Stock
36,628
3
$239.66M
2022-02-28
2022-02-28
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-54,650
3
$239.66M
2022-02-28
2022-02-28
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
54,650
3
$239.66M
2022-02-28
2022-02-28
SETH KIERNAN
VP, Chief Commercial Officer
M - Exercise
Restricted Stock Units
-30,128
3
$239.66M
2022-02-28
2022-02-28
SETH KIERNAN
VP, Chief Commercial Officer
M - Exercise
Common Stock
30,128
3
$239.66M
2022-02-28
2022-02-28
WADE JEFFREY
President and CFO
M - Exercise
Restricted Stock Units
-66,933
3
$239.66M
2022-02-28
2022-02-28
WADE JEFFREY
President and CFO
M - Exercise
Common Stock
66,933
3
$239.66M
2022-02-10
2022-02-14
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Restricted Stock Units
31,850
$0.00
1
$239.66M
2022-02-10
2022-02-14
ALEXANDER KRISTEN
VP, Finance and Accounting
A - Grant
Stock Option (Right to Buy)
47,780
$0.00
1
$239.66M
2022-02-10
2022-02-14
COATS LONNEL
Chief Executive Officer
A - Grant
Restricted Stock Units
274K
$0.00
1
$239.66M
2022-02-10
2022-02-14
COATS LONNEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
822K
$0.00
1
$239.66M
2022-02-10
2022-02-14
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Restricted Stock Units
78,290
$0.00
1
$239.66M
2022-02-10
2022-02-14
CRUM BRIAN
SVP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
235K
$0.00
1
$239.66M
2022-02-10
2022-02-14
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Restricted Stock Units
83,750
$0.00
1
$239.66M
2022-02-10
2022-02-14
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
251K
$0.00
1
$239.66M
2022-02-10
2022-02-14
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Restricted Stock Units
82,670
$0.00
1
$239.66M
2022-02-10
2022-02-14
KASSLER-TAUB KENNETH
SVP, Regulatory & QA
A - Grant
Stock Option (Right to Buy)
248K
$0.00
1
$239.66M
2022-02-10
2022-02-14
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
77,000
$0.00
1
$239.66M
2022-02-10
2022-02-14
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
231K
$0.00
1
$239.66M
2022-02-10
2022-02-14
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Restricted Stock Units
56,830
$0.00
1
$239.66M
2022-02-10
2022-02-14
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Stock Option (Right to Buy)
171K
$0.00
1
$239.66M
2022-02-10
2022-02-14
SETH KIERNAN
VP, Chief Commercial Officer
A - Grant
Restricted Stock Units
68,890
$0.00
1
$239.66M
2022-02-10
2022-02-14
SETH KIERNAN
VP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
207K
$0.00
1
$239.66M
2022-02-10
2022-02-14
WADE JEFFREY
President and CFO
A - Grant
Restricted Stock Units
112K
$0.00
1
$239.66M
2022-02-10
2022-02-14
WADE JEFFREY
President and CFO
A - Grant
Stock Option (Right to Buy)
335K
$0.00
1
$239.66M
2021-04-14
2022-02-11
WADE JEFFREY
President and CFO
G - Gift
Common Stock
-4,500
$0.00
1
$239.66M
2021-07-01
2022-01-10
SOBECKI CHRISTOPHER
G - Gift
Common Stock
-5,700
$0.00
1
$239.66M
2022-01-03
2022-01-04
MCDERMOTT WENDY
VP, Human Resources
A - Grant
Stock Option (Right to Buy)
85,185
$0.00
1
$239.66M
2021-08-02
2021-08-03
GRANOWITZ CRAIG
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$239.66M
2021-04-30
2021-05-03
AMOUYAL PHILIPPE
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
AMOUYAL PHILIPPE
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
BARKER SAM
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
BARKER SAM
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
DEBBANE RAYMOND
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
DEBBANE RAYMOND
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
LEFKOWITZ ROBERT MD
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
LEFKOWITZ ROBERT MD
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
NIES ALAN
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
NIES ALAN
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
PALANTONI FRANK
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
PALANTONI FRANK
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
SOBECKI CHRISTOPHER
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
SOBECKI CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-30
2021-05-03
SWAIN JUDITH
A - Grant
Restricted Stock Units
4,024
$0.00
1
$239.66M
2021-04-30
2021-05-03
SWAIN JUDITH
A - Grant
Stock Option (Right to Buy)
6,475
$0.00
1
$239.66M
2021-04-24
2021-04-27
PALANTONI FRANK
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
AMOUYAL PHILIPPE
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
BARKER SAM
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
BARKER SAM
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
DEBBANE RAYMOND
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
LEFKOWITZ ROBERT MD
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
LEFKOWITZ ROBERT MD
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
NIES ALAN
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
NIES ALAN
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
PALANTONI FRANK
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-10,638
$0.00
1
$239.66M
2021-04-24
2021-04-27
SWAIN JUDITH
M - Exercise
Common Stock
10,638
$0.00
1
$239.66M
2021-03-15
2021-03-16
TESSMER JAMES
VP, Finance & Accounting
S - Sale
Common Stock
-22,912
$7.00
-160K
2
$239.66M
2021-03-15
2021-03-16
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Common Stock
12,000
$3.00
36,000
1
$239.66M
2021-03-15
2021-03-16
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Stock Option (Right to Buy)
-12,000
$0.00
1
$239.66M
2021-02-28
2021-03-02
CRUM BRIAN
VP, General Counsel & Secr.
M - Exercise
Common Stock
38,765
4
$239.66M
2021-02-28
2021-03-02
CRUM BRIAN
VP, General Counsel & Secr.
M - Exercise
Restricted Stock Units
-38,765
4
$239.66M
2021-02-28
2021-03-02
COATS LONNEL
President and CEO
M - Exercise
Common Stock
193K
4
$239.66M
2021-02-28
2021-03-02
COATS LONNEL
President and CEO
M - Exercise
Restricted Stock Units
-193K
4
$239.66M
2021-02-28
2021-03-02
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
F - Tax
Common Stock
-26,584
$7.00
-186K
1
$239.66M
2021-02-28
2021-03-02
TYLE PRAVEEN
EVP, R&D
F - Tax
Common Stock
-16,560
$7.00
-116K
1
$239.66M
2021-02-28
2021-03-02
TESSMER JAMES
VP, Finance & Accounting
F - Tax
Common Stock
-10,765
$7.00
-75,355
1
$239.66M
2021-02-28
2021-03-02
MAIN ALAN
EVP, Innov & Chem Sciences
F - Tax
Common Stock
-20,413
$7.00
-143K
1
$239.66M
2021-02-28
2021-03-02
CRUM BRIAN
VP, General Counsel & Secr.
F - Tax
Common Stock
-14,860
$7.00
-104K
1
$239.66M
2021-02-28
2021-03-02
COATS LONNEL
President and CEO
F - Tax
Common Stock
-55,038
$7.00
-385K
1
$239.66M
2021-02-28
2021-03-02
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Common Stock
28,316
4
$239.66M
2021-02-28
2021-03-02
TYLE PRAVEEN
EVP, R&D
M - Exercise
Restricted Stock Units
-68,007
4
$239.66M
2021-02-28
2021-03-02
TYLE PRAVEEN
EVP, R&D
M - Exercise
Common Stock
68,007
4
$239.66M
2021-02-28
2021-03-02
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
M - Exercise
Restricted Stock Units
-68,109
4
$239.66M
2021-02-28
2021-03-02
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Restricted Stock Units
-28,316
4
$239.66M
2021-02-28
2021-03-02
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
M - Exercise
Common Stock
68,109
4
$239.66M
2021-02-28
2021-03-02
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Common Stock
56,468
4
$239.66M
2021-02-28
2021-03-02
MAIN ALAN
EVP, Innov & Chem Sciences
M - Exercise
Restricted Stock Units
-56,468
4
$239.66M
2021-02-11
2021-02-16
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$239.66M
2021-02-11
2021-02-16
COATS LONNEL
President and CEO
A - Grant
Restricted Stock Units
100K
$0.00
1
$239.66M
2021-02-11
2021-02-16
COATS LONNEL
President and CEO
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$239.66M
2021-02-11
2021-02-16
CRUM BRIAN
VP, General Counsel & Secr.
A - Grant
Restricted Stock Units
26,250
$0.00
1
$239.66M
2021-02-11
2021-02-16
CRUM BRIAN
VP, General Counsel & Secr.
A - Grant
Stock Option (Right to Buy)
78,760
$0.00
1
$239.66M
2021-02-11
2021-02-16
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Restricted Stock Units
26,930
$0.00
1
$239.66M
2021-02-11
2021-02-16
MAIN ALAN
EVP, Innov & Chem Sciences
A - Grant
Stock Option (Right to Buy)
80,780
$0.00
1
$239.66M
2021-02-11
2021-02-16
TESSMER JAMES
VP, Finance & Accounting
A - Grant
Restricted Stock Units
16,230
$0.00
1
$239.66M
2021-02-11
2021-02-16
TESSMER JAMES
VP, Finance & Accounting
A - Grant
Stock Option (Right to Buy)
24,340
$0.00
1
$239.66M
2021-02-11
2021-02-16
TYLE PRAVEEN
EVP, R&D
A - Grant
Restricted Stock Units
32,100
$0.00
1
$239.66M
2021-02-11
2021-02-16
TYLE PRAVEEN
EVP, R&D
A - Grant
Stock Option (Right to Buy)
96,310
$0.00
1
$239.66M
2021-02-11
2021-02-16
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
A - Grant
Restricted Stock Units
33,530
$0.00
1
$239.66M
2020-12-31
2021-01-05
INVUS C.V.
J - Other
Common Stock
-4.32M
1
$239.66M
2020-12-16
2020-12-17
ARTAL INTERNATIONAL S.C.A.
P - Purchase
Common Stock
11M
$3.00
33M
1
$239.66M
2020-12-16
2020-12-17
INVUS PUBLIC EQUITIES, L.P.
P - Purchase
Common Stock
11M
$3.00
33M
1
$239.66M
2020-04-26
2020-04-27
AMOUYAL PHILIPPE
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
SWAIN JUDITH
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
SWAIN JUDITH
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
SOBECKI CHRISTOPHER
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
SOBECKI CHRISTOPHER
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
PALANTONI FRANK
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
PALANTONI FRANK
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
NIES ALAN
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
NIES ALAN
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
LEFKOWITZ ROBERT MD
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
LEFKOWITZ ROBERT MD
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
DEBBANE RAYMOND
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
DEBBANE RAYMOND
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
BARKER SAM
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
BARKER SAM
M - Exercise
Restricted Stock Units
-3,466
$0.00
1
$239.66M
2020-04-26
2020-04-27
AMOUYAL PHILIPPE
M - Exercise
Common Stock
3,466
$0.00
1
$239.66M
2020-04-24
2020-04-27
NIES ALAN
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
AMOUYAL PHILIPPE
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
AMOUYAL PHILIPPE
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
BARKER SAM
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
BARKER SAM
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
DEBBANE RAYMOND
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
DEBBANE RAYMOND
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
LEFKOWITZ ROBERT MD
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
LEFKOWITZ ROBERT MD
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
NIES ALAN
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
PALANTONI FRANK
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
PALANTONI FRANK
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
SOBECKI CHRISTOPHER
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
SOBECKI CHRISTOPHER
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-24
2020-04-27
SWAIN JUDITH
A - Grant
Restricted Stock Units
10,638
$0.00
1
$239.66M
2020-04-24
2020-04-27
SWAIN JUDITH
A - Grant
Stock Option (Right to Buy)
18,115
$0.00
1
$239.66M
2020-04-22
2020-04-24
CRUM BRIAN
VP, General Counsel & Secr.
A - Grant
Common Stock
19,893
$0.00
1
$239.66M
2020-04-22
2020-04-24
LAPUERTA PABLO
EVP and CMO
A - Grant
Common Stock
19,893
$0.00
1
$239.66M
2020-04-22
2020-04-24
MAIN ALAN
EVP, Commercial Supply Ops
A - Grant
Common Stock
19,893
$0.00
1
$239.66M
2020-04-22
2020-04-24
SANTINI ALEXANDER
EVP and CCO
A - Grant
Common Stock
19,893
$0.00
1
$239.66M
2020-04-22
2020-04-24
TESSMER JAMES
VP, Finance & Accounting
A - Grant
Common Stock
13,262
$0.00
1
$239.66M
2020-04-22
2020-04-24
TYLE PRAVEEN
EVP, R&D
A - Grant
Common Stock
19,893
$0.00
1
$239.66M
2020-04-22
2020-04-24
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
A - Grant
Common Stock
26,525
$0.00
1
$239.66M
2020-04-22
2020-04-24
CRUM BRIAN
VP, General Counsel & Secr.
F - Tax
Common Stock
-6,398
$2.00
-12,796
1
$239.66M
2020-04-22
2020-04-24
LAPUERTA PABLO
EVP and CMO
F - Tax
Common Stock
-6,813
$2.00
-13,626
1
$239.66M
2020-04-22
2020-04-24
MAIN ALAN
EVP, Commercial Supply Ops
F - Tax
Common Stock
-6,813
$2.00
-13,626
1
$239.66M
2020-04-22
2020-04-24
SANTINI ALEXANDER
EVP and CCO
F - Tax
Common Stock
-6,813
$2.00
-13,626
1
$239.66M
2020-04-22
2020-04-24
TESSMER JAMES
VP, Finance & Accounting
F - Tax
Common Stock
-3,997
$2.00
-7,994
1
$239.66M
2020-04-22
2020-04-24
TYLE PRAVEEN
EVP, R&D
F - Tax
Common Stock
-4,844
$2.00
-9,688
1
$239.66M
2020-04-22
2020-04-24
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
F - Tax
Common Stock
-9,651
$2.00
-19,302
1
$239.66M
2020-02-28
2020-03-03
MAIN ALAN
EVP, Commercial Supply Ops
M - Exercise
Restricted Stock Units
-37,252
4
$239.66M
2020-02-28
2020-03-03
MAIN ALAN
EVP, Commercial Supply Ops
M - Exercise
Common Stock
37,252
4
$239.66M
2020-02-28
2020-03-03
SANTINI ALEXANDER
EVP and CCO
M - Exercise
Restricted Stock Units
-36,263
4
$239.66M
2020-02-28
2020-03-03
SANTINI ALEXANDER
EVP and CCO
M - Exercise
Common Stock
36,263
4
$239.66M
2020-02-28
2020-03-03
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Restricted Stock Units
-16,396
4
$239.66M
2020-02-28
2020-03-03
TESSMER JAMES
VP, Finance & Accounting
M - Exercise
Common Stock
16,396
4
$239.66M
2020-02-28
2020-03-03
TYLE PRAVEEN
EVP, R&D
M - Exercise
Restricted Stock Units
-39,316
3
$239.66M
2020-02-28
2020-03-03
TYLE PRAVEEN
EVP, R&D
M - Exercise
Common Stock
39,316
3
$239.66M
2020-02-28
2020-03-03
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
M - Exercise
Restricted Stock Units
-42,138
4
$239.66M
2020-02-28
2020-03-03
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
M - Exercise
Common Stock
42,138
4
$239.66M
2020-02-28
2020-03-03
COATS LONNEL
President and CEO
F - Tax
Common Stock
-45,320
$3.00
-136K
1
$239.66M
2020-02-28
2020-03-03
CRUM BRIAN
VP, General Counsel & Secr.
F - Tax
Common Stock
-6,940
$3.00
-20,820
1
$239.66M
2020-02-28
2020-03-03
LAPUERTA PABLO
EVP and CMO
F - Tax
Common Stock
-13,305
$3.00
-39,915
1
$239.66M
2020-02-28
2020-03-03
MAIN ALAN
EVP, Commercial Supply Ops
F - Tax
Common Stock
-12,759
$3.00
-38,277
1
$239.66M
2020-02-28
2020-03-03
SANTINI ALEXANDER
EVP and CCO
F - Tax
Common Stock
-12,420
$3.00
-37,260
1
$239.66M
2020-02-28
2020-03-03
TESSMER JAMES
VP, Finance & Accounting
F - Tax
Common Stock
-3,902
$3.00
-11,706
1
$239.66M
2020-02-28
2020-03-03
WADE JEFFREY
EVP, Corp Adm Affairs and CFO
F - Tax
Common Stock
-16,025
$3.00
-48,075
1
$239.66M
2020-02-28
2020-03-03
COATS LONNEL
President and CEO
M - Exercise
Restricted Stock Units
-117K
4
$239.66M
2020-02-28
2020-03-03
COATS LONNEL
President and CEO
M - Exercise
Common Stock
117K
4
$239.66M